Thymosin Beta-4 Peptide Reduces Heart Scarring After Heart Attack by Regulating the ROCK1 Protein

Researchers performed permanent coronary artery ligation in adult mice to induce heart attacks, then administered TB4 via systemic injection. MiRNA profiling was conducted on heart tissue from TB4-treated and untreated mice to identify differentially expressed microRNAs. Target analysis identified ROCK1 as a candidate protein. Validation was performed using real-time PCR, Western blot, and immunostaining in both adult mouse hearts (in vivo) and human cardiac cells (in vitro) to confirm TB4's effect on ROCK1 expression and fibroblast-to-myofibroblast transformation.

Heart attacks affect millions of people annually, and the scar tissue that forms afterward is a leading cause of heart failure. Current treatments can open blocked arteries but cannot regenerate damaged heart muscle or prevent scarring. TB4's ability to reduce pathological scarring through a defined molecular mechanism (ROCK1 regulation) provides a concrete therapeutic target. Since ROCK1 inhibitors are already being studied for various cardiac conditions, TB4 may offer a peptide-based approach to achieve similar benefits.

Thymosin beta-4 has been studied for cardiac repair since landmark work showed it could reactivate progenitor cells and promote coronary vessel regrowth after heart attack. This study advances the mechanistic understanding by identifying a specific molecular pathway — the miR-139-5p/ROCK1 axis — through which TB4 reduces fibrosis. ROCK inhibitors (like fasudil) are already in clinical use for other conditions, so demonstrating that TB4 acts as a natural ROCK1 modulator bridges peptide biology and small-molecule pharmacology, potentially opening combination therapy approaches for post-infarction cardiac repair.

The study was conducted in mouse models and human cell lines, not in human patients, so clinical translation is uncertain. The permanent coronary ligation model creates more severe damage than most human heart attacks (where reperfusion therapy is standard). The study identified an association between TB4 and ROCK1 modulation but the precise mechanism — whether direct or indirect — remains to be fully elucidated. Sample sizes for the animal experiments were not specified in the abstract.